Eli Lilly and Company

HUMULIN R U-500

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Eli Lilly and Company

Humulin R U-500 HCPCS:

S5550

HCPCS Code Descriptor:

Insulin, rapid onset, 5 units

Category:

S Code

Humulin R U-500 NDCs:

No actively aligned NDCs found

Primary Type:

Insulin

Generic/Specialty Status:

Single-Source

Package Type:

Multiple

Route of Administration:

Subcutaneous

Humulin R U-500 CPT Codes:

Potential CPT administration codes for Humulin R U-500 can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Humulin R U-500:

HUMULIN R U-500 is an Insulin drug manufactured by Eli Lilly and Company and administered via the Subcutaneous route of administration. The S Code: S5550 is aligned to the drug HUMULIN R U-500.

Humulin R U-500 is a highly concentrated form of insulin, containing up to five times as much insulin as standard insulin shots. It is used to lower blood sugar in patients with a variety of types of diabetes. Humulin R U-500 may be recommended for patients who are taking more than 200 units of insulin each day with A1C levels still above target levels. Humulin R U-500 may be preferable to some patients as it covers both long-acting and mealtime insulin needs, which may mean fewer injections each day.

ACCESS PRICING AND MORE BY REGISTERING

S5550 Added Date:

October 1, 2003

S5550 Effective Date:

October 1, 2003

S5550 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Humulin R U-500 billing and coding information.
Humulin R U-500 patient assistance information can be found through the Lilly Cares Foundation at the URL: http://www.lillycares.com
HUMULIN R U-500 prescribing information can be found at the link below:
Information regarding HUMULIN R U-500’s side effects can be found at MedlinePlus